[P4–576]: FIRST‐IN‐HUMAN PHASE I RESULTS SHOW SAFETY, TOLERABILITY AND BRAIN PENETRANCE OF ORY‐2001, AN EPIGENETIC DRUG TARGETING LSD1 AND MAO‐B. (1st July 2017) - Maes, Tamara